TEAMM Pharmaceuticals, Inc., An Accentia BioPharmaceuticals Company, Announces The Signing Of A Marketing And Sales Agreement With Arius Pharmaceuticals
10/19/2005 5:08:46 PM
TEAMM Pharmaceuticals, the commercial arm of Accentia BioPharmaceuticals, announced today the signing of a marketing and sales agreement with Arius Pharmaceuticals, Inc. for the exclusive rights to market and sell Arius's product for treatment of nausea and vomiting. TEAMM Pharmaceuticals is focused on targeted therapies in the areas of respiratory, pain, oncology and critical care.
comments powered by